Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer.
Hou Z, Huang S, Mei Z, Chen L, Guo J, Gao Y, Zhuang Q, Zhang X, Tan Q, Yang T, Liu Y, Chi Y, Qi L, Jiang T, Shao X, Wu Y, Xu X, Qin J, Ren R, Tang H, Wu D, Li Z.
Hou Z, et al. Among authors: li z.
Cell Rep Med. 2022 Mar 15;3(3):100561. doi: 10.1016/j.xcrm.2022.100561. eCollection 2022 Mar 15.
Cell Rep Med. 2022.
PMID: 35492874
Free PMC article.